Global Allopurinol Market, By Drug Class (Antigout Agents, Antihyperuricemic Agents), Application (Gout, Kidney Stones, Others), Demographic (Adult, Pediatric), Dosage Form (Intravenous Powder for Injection, Oral Tablet), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Allopurinol Market
Allopurinol market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6% in the above mentioned forecast period.
Allopurinol lowers uric acid synthesis in the body. Gout and kidney stones can be caused by an accumulation of uric acid in the body. Gout and kidney stones are treated with allopurinol. Allopurinol is also used to lower uric acid levels in persons undergoing cancer treatment. Zyloprim and Lopurin are brand names for allopurinol oral tablet, which is a prescription medicine. It can also be purchased as a generic medicine.
The rise in the incidences of kidney stones and gout across the world will act a major driver for the expansion of allopurinol market. Furthermore, increasing geriatric population, rising healthcare expenditure and increase in the demand from various end-use industries are the factors that will expand the allopurinol market. Other factors including rise in the level of disposable income, rapid urbanization and rising awareness will positively impact the market growth rate.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the allopurinol market in the forecast period of 2022-2029.
However, high cost of the drug and side effects associated with allopurinol such loss of appetite, dizziness, fever, chills, blood in urine, skin rash and others. All these factors hamper the market growth. Lack of awareness will further challenge the allopurinol market in the forecast period mentioned above.
This allopurinol market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the allopurinol market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Allopurinol Market Scope and Market Size
The allopurinol market is segmented on the basis of drug class, application, demographic, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the allopurinol market is segmented into antigout agents, and antihyperuricemic agents.
- On the basis of application, the allopurinol market is segmented into gout, kidney stones, and others.
- On the basis of demographic, the allopurinol market is segmented into adult, and pediatric.
- On the basis of dosage form, the allopurinol market is segmented into intravenous powder for injection, and oral tablet. Intravenous powder for injection is further sub-segmented into 500mg. Oral tablet is further sub-segmented into 100mg and 300mg.
- On the basis of end-users, the allopurinol market is segmented into clinic, hospital and others.
- The allopurinol market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Allopurinol Market Country Level Analysis
Allopurinol market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, end-users and distribution channel as referenced above.
The countries covered in the allopurinol market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the allopurinol market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Allopurinol market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Allopurinol Market Share Analysis
Allopurinol market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to allopurinol market research.
Some of the major players operating in the allopurinol market are Dr. Reddy’s Laboratories Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., Apotex Inc., Accord Healthcare, Casper Pharma, Ipca Laboratories Ltd., Unichem Laboratories, Wellona Pharma Private Limited, Harman Finochem Ltd., Om Pharmaceutical Industries, Octavius Pharma Pvt. Ltd., INDOCO REMEDIES LTD., among others.
SKU-